American Society of Clinical Oncology (ASCO)
-
Publisher Of
-
Precision Pathology as Part of Precision Medicine: Are We Optimizing Patients’ Interests in Prioritizing Use of Limited Tissue Samples?.
Jco Precision Oncology.
1-6.
2019
-
Characterization of the Epidermal Growth Factor Receptor T790M Mutation in Colorectal Cancer.
Jco Precision Oncology.
1-7.
2018
-
Geriatric Assessment: Precision Medicine for Older Adults With Cancer.
Journal of Oncology Practice.
14:97-98.
2018
-
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
35:2260-2267.
2017
-
Changes in skeletal muscle cross sectional area (CSA) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZ)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
34:e16601-e16601.
2016
-
Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology Consensus Guideline.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
32:1502-1506.
2014
-
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
32:1365-1383.
2014
-
Comparative Effectiveness Research: The Experience of the National Institute for Health and Clinical Excellence.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:4267-4274.
2012
-
Reply to F. Perrone et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:2801-2801.
2012
-
Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Journal of Oncology Practice.
8:e59-e61.
2012
-
Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline.
Journal of Oncology Practice.
8:e65-e66.
2012
-
Vitamin E and the risk of prostate cancer: Updated results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:7-7.
2012
-
Discovering pathways in the tumor microenvironment important for recurrence-free survival in patients with colorectal liver metastasis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:480-480.
2012
-
Predictive and prognostic markers of recurrence after resection of primary or metastatic colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30:447-447.
2012
-
A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:TPS223-TPS223.
2011
-
Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e13556-e13556.
2011
-
Phase I pharmacodynamic trial of sequential sunitinib (SU) with bevacizumab (bev) in patients with renal cell carcinoma (mRCC) and other advanced solid malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:e13503-e13503.
2011
-
Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following clinical benefit from prior standard cytotoxic chemotherapy (CT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:10005-10005.
2011
-
Symptom experiences and nonadherent medication-taking behaviors of breast cancer patients taking adjuvant hormone therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:524-524.
2011
-
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:198-198.
2011
-
A phase I study of erlotinib, bevacizumab, and external beam radiation therapy (RT) for patients with localized pancreatic carcinoma (PC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
29:281-281.
2011
-
A randomized, double-blind, placebo-controlled phase III trial comparing docetaxel, prednisone, and placebo with docetaxel, prednisone, and bevacizumab in men with metastatic castration-resistant prostate cancer (mCRPC): Survival results of CALGB 90401..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:LBA4511-LBA4511.
2010
-
A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501): Results of a planned interim analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:8106-8106.
2010
-
A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:TPS306-TPS306.
2010
-
Characterization of proliferative rebound during drug holiday by FLT-PET imaging in patients treated with sunitinib (SU)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:3094-3094.
2010
-
Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:3050-3050.
2010
-
Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:8039-8039.
2010
-
Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2060-2060.
2010
-
Influence of radiation modality and nodal dissection on survival in high-risk early-stage endometrial cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:5027-5027.
2010
-
Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
28:2055-2055.
2010
-
Erratum.
Journal of Oncology Practice.
6:110-110.
2010
-
Filling the Gap: Development of the Oncology Nurse Practitioner Workforce.
Journal of Oncology Practice.
6:2-6.
2010
-
A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2010b-2010b.
2008
-
Bevacizumab and daily temozolomide for recurrent glioblastoma multiforme (GBM).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:2074-2074.
2008
-
Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:4063-4063.
2008
-
Ki67 and PIM1 expression in aggressively treated mantle cell lymphoma (MCL): A Cancer and Leukemia Group B (CALGB) 59909 correlative science study.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:8560-8560.
2008
-
ERRATUM.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:1018-1018.
2008
-
In Reply:.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
26:1013-1013.
2008
-
American Society of Clinical Oncology 2007 Clinical Practice Guideline Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer.
Journal of Oncology Practice.
3:326-329.
2007
-
In Reply:.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
23:8537-8538.
2005
-
Erratum.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
23:1337-1337.
2005
-
In Reply:.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
23:1322-1323.
2005
-
A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3555-3555.
2018
-
A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4121-4121.
2018
-
Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5590-5590.
2018
-
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6620-6620.
2018
-
Comparison of cancer incidence to available oncology clinical trial slots..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18615-e18615.
2018
-
Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5507-5507.
2018
-
Development of a digital patient navigation application: Results from subject interviews..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22146-e22146.
2018
-
Immune profiling of BRCA-mutated breast cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
585-585.
2018
-
Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4030-4030.
2018
-
Meeting the needs of women at high risk for breast cancer: Facilitated group visits..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18508-e18508.
2018
-
Multi institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4082-4082.
2018
-
Patient(Pt)-reported toxicities by chemotherapy regimen for early breast cancer (BC) (LCCC1334/1440)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
544-544.
2018
-
Patient(Pt)-reported toxicities during breast cancer (BC) chemotherapy (CRx): Associations with pre-treatment (Tx) measures of quality of life (QOL) and Tx discontinuation..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
546-546.
2018
-
Phase 1 study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Final efficacy and safety data..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9557-9557.
2018
-
Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11512-11512.
2018
-
Physicians’ comfort levels with prescriptions for cancer comorbidities that they and other healthcare providers write..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18523-e18523.
2018
-
Recombinant oncolytic poliovirus combined with checkpoint blockade for breast cancer therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e12641-e12641.
2018
-
The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
587-587.
2018
-
Using a geriatric oncology assessment to link with services in an underserved, community oncology population..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22024-e22024.
2018
-
Androgen deprivation therapy (ADT) and cardiovascular mortality (CVD) in men with early-stage prostate cancer (PC) receiving curative radiation therapy (RT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
127-127.
2018
-
Assessing key stakeholders' knowledge, needs, and preferences for cancer survivorship care plans..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
30-30.
2018
-
Cardiovascular disease-related chronic conditions among Veterans Affairs colorectal cancer survivors: A matched case-control analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4-4.
2018
-
Development of a digital patient navigation application: Preliminary results from patient interviews..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
161-161.
2018
-
Perceptions of unintentional weight loss among cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
138-138.
2018
-
Text messaging and activity tracker motivation program to increase physical activity in cancer survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
92-92.
2018
-
A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS395-TPS395.
2018
-
A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS710-TPS710.
2018
-
Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: Subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
582-582.
2018
-
Clinical utility of Foundation One tissue molecular profiling in men with metastatic prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
318-318.
2018
-
Consensus statement on circulating biomarkers for advanced prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
299-299.
2018
-
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
191-191.
2018
-
Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
160-160.
2018
-
Impact of enzalutamide (ENZA) vs. bicalutamide (BIC) on health-related quality of life (HRQoL) of patients (pts) with castration-resistant prostate cancer (CRPC): STRIVE study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
234-234.
2018
-
Interim analysis of a prospective randomized trial of dietary carbohydrate restriction for men with a rising PSA after failed primary treatment: Carbohydrate and Prostate Study 2 (CAPS2)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
382-382.
2018
-
Luminal and basal subtyping of metastatic castration-resistant prostate cancer (mCRPC) and its clinical implications..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
197-197.
2018
-
Optimal timing of post-prostatectomy radiotherapy for prostate cancer with high-risk pathologic features: A multi-institutional analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
24-24.
2018
-
Patients perspectives on adjuvant therapy in renal cell carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
644-644.
2018
-
Patterns of progression in bone and soft tissue following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
222-222.
2018
-
Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11-11.
2018
-
Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
576-576.
2018
-
Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
415-415.
2018
-
S-TRAC trial: Sensitivity analyses of disease-free survival (DFS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
633-633.
2018
-
Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
278-278.
2018
-
Association of RAS mutations with race in metastatic colorectal cancer: CALGB/SWOG 80405 (ALLIANCE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
638-638.
2018
-
BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS873-TPS873.
2018
-
Role of adjuvant chemotherapy following chemoradiation and surgery for locoregionally advanced rectal cancer: A Veterans Health Administration analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
741-741.
2018
-
Serial monitoring of ctDNA to highlight mutation profiles in colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
641-641.
2018
-
Four Conversations: A randomized control trial of an online, shared decision making curriculum among the metastatic breast cancer community..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
47-47.
2017
-
Integration and expansion of palliative care work force..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
126-126.
2017
-
Open notes: A qualitative study of oncology patients’ experiences reading their cancer care notes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
33-33.
2017
-
Perceptions of prognosis and treatment risk in older patients with acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
43-43.
2017
-
Use of hospice services among Medicare beneficiaries with acute and chronic leukemias..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
68-68.
2017
-
A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
532-532.
2017
-
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemictabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5532-5532.
2017
-
A randomized, phase II efficacy assessment of multiple MET kinase inhibitors in metastatic papillary renal carcinoma (PRCC): SWOG S1500..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS4599-TPS4599.
2017
-
Biomarker modulation in patients treated with TRC105 in combination with anti-VEGF therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11546-11546.
2017
-
Bridging the financial assistance gap: A pilot study of a patient-facing app to identify drug financial assistance programs..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18296-e18296.
2017
-
Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5034-5034.
2017
-
Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6608-6608.
2017
-
Dose escalation results of a phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in patients (Pts) with relapsed/refractory (r/r) acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7027-7027.
2017
-
Dose finding study of the intratumoral administration of the oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13533-e13533.
2017
-
Evaluation of microarrays for measuring cell cycle progression (CCP) gene expression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16566-e16566.
2017
-
Impact of hearing and visual impairment in older adults with cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10036-10036.
2017
-
Molecular genetic testing patterns for patients with newly diagnosed acute myeloid leukemia (AML) enrolled in the CONNECT MDS/AML disease registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7022-7022.
2017
-
Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11008-11008.
2017
-
Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2049-2049.
2017
-
Overall survival (OS) and stem cell transplant (SCT) in patients with FLT3 mutations treated with CPX-351 versus 7+3: Subgroup analysis of a phase III study of older adults with newly diagnosed, high-risk acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18507-e18507.
2017
-
Overall survival (OS) with CPX-351 versus 7+3 in older adults with newly diagnosed, therapy-related acute myeloid leukemia (tAML): Subgroup analysis of a phase III study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7035-7035.
2017
-
Patient-reported distress in myelodysplastic syndromes and its relationship with clinical outcomes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21564-e21564.
2017
-
Phase 1 single-center, dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13532-e13532.
2017
-
Phase I/II dose expansion of a trial investigating bendamustine and pomalidomide with dexamethasone (BPd) in patients with relapsed/refractory multiple myeloma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8008-8008.
2017
-
Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS3630-TPS3630.
2017
-
Reductions in exercise behavior and tumor progression in newly diagnosed glioblastoma (GBM) patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e21636-e21636.
2017
-
Risk tolerance and attitudes toward chemotherapy: Who chooses palliative treatment when cure is possible?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10054-10054.
2017
-
Role of axillary node dissection after mastectomy with positive sentinel nodes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
554-554.
2017
-
Short- and long-term outcomes of early stage non-small cell lung cancer (NSCLC) surgery..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8544-8544.
2017
-
Temporal associations between prognostic indicators and overall survival after breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e18144-e18144.
2017
-
Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8546-8546.
2017
-
A nomogram for testosterone recovery following combined androgen deprivation therapy and radiation therapy for prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
67-67.
2017
-
Head-to-head pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprorelin acetate formulations in male patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e589-e589.
2017
-
Inpatient integrated palliative and transplant care to improve family caregiver (FC) outcomes of patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
235-235.
2016
-
Patient-reported distress in adults with myelodysplastic syndromes (MDS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
80-80.
2016
-
Randomized trial of inpatient palliative care in patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
103-103.
2016
-
Sleep quality among inpatients with acute myeloid leukemia..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
82-82.
2016
-
The elephant in the room: Facilitating conversations about advanced cancer between patients and their spouses..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
233-233.
2016
-
Who chooses palliative chemotherapy when a cure is possible? Results of a risk tolerance survey of laypersons..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
35-35.
2016
-
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8508-8508.
2016
-
Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma from the JAVELIN solid tumor phase 1b trial: Analysis of safety, clinical activity, and PD-L1 expression..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4514-4514.
2016
-
Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3597-3597.
2016
-
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3503-3503.
2016
-
NRG BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS1098-TPS1098.
2016
-
Patient survival on the dose escalation phase of the Oncolytic Polio/Rhinovirus Recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG) clinical trial compared to historical controls..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2061-2061.
2016
-
Phase I trial of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly-diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13518-e13518.
2016
-
Phase II evaluation of nintedanib in the treatment of bevacizumab-resistant persistent/recurrent ovarian, fallopian tube, or primary peritoneal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS5601-TPS5601.
2016
-
Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3548-3548.
2016
-
Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e15013-e15013.
2016
-
Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin–paclitaxel (CP) ± bevacizumab (BEV): Results from GOG-0218..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5521-5521.
2016
-
Randomized trial of an inpatient palliative care intervention in patients hospitalized for hematopoietic stem cell transplantation (HCT)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10004-10004.
2016
-
Surgery versus optimal medical management of early-stage small cell lung cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8511-8511.
2016
-
Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3061-3061.
2016
-
Validation and quality assessment of the Kilimanjaro Cancer Registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
266-266.
2016
-
Changing characteristics of patients treated with sipuleucel-T (sip-T) over time: Real-world experience from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
320-320.
2016
-
Objective response of the dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist, VT-464, in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
273-273.
2016
-
Once-nightly (QD) dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist VT-464 in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
343-343.
2016
-
Fatigue in long-term non-Hodgkin lymphoma survivors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
239-239.
2015
-
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3599-3599.
2015
-
A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5500-5500.
2015
-
Acute Myeloid Leukemia (AML) PatientsÂ’ Understanding of Prognosis and Treatment Goals: A Mixed-Methods Study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17741-e17741.
2015
-
Administration of sipuleucel-T (sip-T) infusions (infs) outside of the clinical trial setting: Data from the PROCEED registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16027-e16027.
2015
-
Carboxyamidotriazole orotate (CTO) in combination with bevacizumab (BEV) for adult patients with recurrent malignant glioma post-BEV failure: Phase 1..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2067-2067.
2015
-
Disparities in cancer treatment among HIV-infected individuals..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17592-e17592.
2015
-
Duke University Global Cancer Program: A multidisciplinary approach to partnerships in global cancer care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17584-e17584.
2015
-
Effect of alphavirus vaccine encoding HER2 during concurrent anti-HER2 therapies on induction of oligoclonal T cell and antibody responses against HER2..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3081-3081.
2015
-
Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5011-5011.
2015
-
Epidermal growth factor receptor (EGFR) testing among veterans diagnosed with lung cancer in the VA..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17582-e17582.
2015
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5042-5042.
2015
-
Grip strength and timed get-up-and-go: Associations with symptoms among women taking adjuvant endocrine therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e11564-e11564.
2015
-
HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3583-3583.
2015
-
HIF inhibition in metastatic renal cell carcinoma (mRCC): Final results of a phase Ib /IIa clinical trial evaluating the nanoparticle drug conjugate (NDC), CRLX101, in combination with bevacizumab (bev)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4543-4543.
2015
-
Implementation of gene expression testing for breast cancer patients within the Veterans Health Administration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17511-e17511.
2015
-
Nationwide utilization of cardiac imaging in patients undergoing cardiotoxic chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6592-6592.
2015
-
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma (GBM): Optimal dose determination..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2068-2068.
2015
-
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3585-3585.
2015
-
Pan-caspase peptide inhibitor to induce primary chronic lymphocytic leukemia (CLL) cell death through a non-apoptotic and non-necroptotic mechanism..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13536-e13536.
2015
-
Patients' and physicians' risk-benefit trade-off preferences for metastatic colorectacl cancer treatments..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3591-3591.
2015
-
Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13004-e13004.
2015
-
Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13030-e13030.
2015
-
Phase II study of bevacizumab and vorinostat for recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2034-2034.
2015
-
Phase II trial of dovitinib in recurrent glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2050-2050.
2015
-
Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3010-3010.
2015
-
Randomized head-to-head prospective study of pharmacokinetic and pharmacodynamic properties of leuprolide acetate formulations: 7.5 mg single depot subcutaneous vs 7.5 mg intramuscular microsphere..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16048-e16048.
2015
-
Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4005-4005.
2015
-
ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2009-2009.
2015
-
Risk factors for interval advanced colorectal neoplasia after screening colonoscopy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3539-3539.
2015
-
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer (LARC): Final results of a phase Ib study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3517-3517.
2015
-
Survival benefit of tumor treating fields plus stereotactic radiosurgery for recurrent malignant gliomas..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13036-e13036.
2015
-
Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3054-3054.
2015
-
The Prostate Cancer Working Group 3 (PCWG3) consensus for trials in castration-resistant prostate cancer (CRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5000-5000.
2015
-
Updated survival results from a randomized, dose-ranging phase II study of nivolumab (NIVO) in metastatic renal cell carcinoma (mRCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4553-4553.
2015
-
Utilization of BRCA1/BRCA2 testing in Veterans Health Administration..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e17510-e17510.
2015
-
Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3503-3503.
2015
-
The oral CYP17-Lyase (L) inhibitor VT-464 in patients with CRPC..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
187-187.
2015
-
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
306-306.
2015
-
Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
278-278.
2015
-
A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9612-9612.
2014
-
A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS11135-TPS11135.
2014
-
A randomized phase II trial of bevacizumab (BV) plus oral everolimus (EV) versus bevacizumab alone for recurrent or persistent epithelial ovarian (EOC), fallopian tube (FTC), or primary peritoneal cancer (PPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5546-5546.
2014
-
A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), ± docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA following definitive local therapy: Safety results..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5022-5022.
2014
-
ABT-199 (GDC-0199) combined with rituximab (R) in patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Interim results of a phase 1b study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7013-7013.
2014
-
Absence of occult micrometastases in histologically negative lymph nodes among patients with distant recurrent endometrial cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5606-5606.
2014
-
Association between CT utilization and radiation therapy at the end of life (EOL) in elderly breast and prostate cancer patients..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6529-6529.
2014
-
Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7568-7568.
2014
-
Association of adjuvant chemotherapy with improved survival after esophagectomy without induction therapy for node-positive adenocarinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4077-4077.
2014
-
Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (ALLIANCE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16061-e16061.
2014
-
Biomarker modulation in patients (pts) receiving TRC105 (T) and bevacizumab (B) in a phase Ib clinical trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11020-11020.
2014
-
Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6615-6615.
2014
-
Change in palliative performance scale score as prediction of survival in patients with advanced cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9561-9561.
2014
-
Changes in androgen deprivation therapy overuse: Reimbursement response and characteristics of persistent overusers..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5044-5044.
2014
-
Clinical benefit of docetaxel or enzalutamide after progression on first-line abiraterone acetate and prednisone in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16031-e16031.
2014
-
Clinical trial subjects compared to "real world" patients: Generalizability of renal cell carcinoma trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6510-6510.
2014
-
Combinatorial TGF-β signaling blockade and anti-CTLA-4 antibody immunotherapy in a murine BRAFV600E-PTEN-/- transgenic model of melanoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3011-3011.
2014
-
Connect MDS and AML: The myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) disease registry..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS7126-TPS7126.
2014
-
Correlation between the international consensus definition of the cancer anorexia cachexia syndrome (CACS) and patient outcomes in advanced non-small cell lung cancer (NSCLC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19042-e19042.
2014
-
Does cancer treatment-related financial distress worsen over time?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6559-6559.
2014
-
Endometrial cancer outcomes in hypertensive women treated with beta-blocker..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16545-e16545.
2014
-
Evaluation of an online, skill-building, group intervention for cancer patients and caregivers: Pillars4Life..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9573-9573.
2014
-
Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study (CCSS)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10023-10023.
2014
-
Exploring variations in multiple myeloma management through in-practice research..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e19534-e19534.
2014
-
Final analysis of a large, open-label global early access protocol (EAP) with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after chemotherapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5061-5061.
2014
-
Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3611-3611.
2014
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16059-e16059.
2014
-
Geographic variation in high-risk uterine cancer histology and access to care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e16546-e16546.
2014
-
Identification and validation of actionable mutations in solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e22149-e22149.
2014
-
Immunotherapeutic treatment of metastatic colorectal cancer using ETBX-011..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3093-3093.
2014
-
Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6508-6508.
2014
-
Is advanced imaging in early-stage breast cancer ever warranted? Exploring benchmarks for an ASCO Choosing Wisely quality measure..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6503-6503.
2014
-
Long-term survivorship in adult primary glioblastoma: Clinical and neurological outcomes of a large, single-center study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9519-9519.
2014
-
Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among U.S. veterans..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3535-3535.
2014
-
Molecular profiling of bile duct and gallbladder cancer to identify different therapeutic options..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4097-4097.
2014
-
Nodal stage of surgically resected non-small cell carcinoma of the lung and its effect on recurrence pattern and survival..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7552-7552.
2014
-
Persistent pain following breast cancer surgery: A case-control study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
9579-9579.
2014
-
Phase 1, open-label, dose-escalation, and expansion study of ABT-700, an anti-C-met antibody, in patients (pts) with advanced solid tumors..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2507-2507.
2014
-
Phase I study of Debio1143 (AT406) in combination with daunorubicin (D) and cytarabine (C) in patients with poor-risk acute myeloid leukemia (AML)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7029-7029.
2014
-
Phase I study of the intratumoral administration of an oncolytic polio/rhinovirus recombinant (PVSRIPO) in recurrent glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2106-TPS2106.
2014
-
Physician experience and attitudes toward addressing the cost of cancer care..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6561-6561.
2014
-
Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5007-5007.
2014
-
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
11022-11022.
2014
-
Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
4532-4532.
2014
-
Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): A report from the Children’s Oncology Group (COG)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10003-10003.
2014
-
Randomized phase IIb study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS2101-TPS2101.
2014
-
Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3069-3069.
2014
-
Relative influence of factors determining a woman’s preference for treatment options in ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5544-5544.
2014
-
Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5054-5054.
2014
-
Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2082-2082.
2014
-
Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
8040-8040.
2014
-
The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3634-3634.
2014
-
The site of visceral metastases (mets) to predict overall survival (OS) in castration-resistant prostate cancer (CRPC) patients (pts): A meta-analysis of five phase III trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5002-5002.
2014
-
Validation of postinduction Curie scores in high-risk neuroblastoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10031-10031.
2014
-
Validation of the MIBG SIOPEN scoring method in two independent high-risk neuroblastoma trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
10029-10029.
2014
-
When is a pathologic diagnosis preferred before stereotactic ablative radiotherapy for stage I lung cancer? A decision analysis..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7534-7534.
2014
-
When should surgeons begin surveillance with CT scans after lobectomy for stage 1A non-small cell lung cancer?.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7549-7549.
2014
-
Effect of prior abiraterone (ABI) or enzalutamide (ENZ) on sipuleucel-T (sip-T) manufacture in PROCEED patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
185-185.
2014
-
Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
LBA1-LBA1.
2014
-
Evidence for circulating tumor cell (CTC) alkaline phosphatase (AP) expression in men with bone-metastatic castration-resistant prostate cancer (CRPC) during abiraterone acetate treatment..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
178-178.
2014
-
Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
65-65.
2014
-
Impact of prior radiation treatment (tx) on sipuleucel-T (sip-T) product parameters in PROCEED patients (pts)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
183-183.
2014
-
Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
64-64.
2014
-
Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
455-455.
2014
-
Open versus minimally invasive management of gastric GIST: An international multi-institutional analysis of short- and long-term outcomes..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
85-85.
2014
-
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
448-448.
2014
-
Patient-oncologist cost communication, financial distress, and medication adherence..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
2-2.
2013
-
Tools to accurately identify veterans who undergo molecular diagnostic testing..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
201-201.
2013
-
A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
105-105.
2013
-
Efficacy and safety of zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (Alliance)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
27-27.
2013
-
The BEST trial (E2804): A randomized phase II study of VEGF, RAF kinase, and mTOR combination targeted therapy (CTT) with bevacizumab (bev), sorafenib (sor), and temsirolimus (tem) in advanced renal cell carcinoma (RCC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
345-345.
2013
-
Value of NADiA ProsVue on the CAPRA-S nomogram for predicting postprostatectomy clinical recurrence..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
139-139.
2013
-
A molecular profile of colorectal cancer to guide prognosis and therapy after resection of primary or metastatic disease..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
339-339.
2013
-
TH-302 plus gemcitabine (G+T) versus gemcitabine (G) in patients with previously untreated advanced pancreatic cancer (PAC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
325-325.
2013
-
Use of a novel patient-specific model of glioma growth kinetics to elucidate underlying biology as measured by gene expression microarray..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
71-71.
2012
-
CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
CRA9013-CRA9013.
2012
-
A phase I/II study of capecitabine (Cape), oxaliplatin (Ox), panitumumab (Pmab), and external beam radiation therapy (RT) for patients with esophagogastric carcinoma (EC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
68-68.
2012
-
Patterns of failure following trimodality therapy for locally advanced esophageal cancer (EC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
88-88.
2012
-
A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
92-92.
2011
-
A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6520-6520.
2011
-
Adaptive design of VALOR, a phase III trial of vosaroxin or placebo in combination with cytarabine for patients with first relapsed or refractory acute myeloid leukemia..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
TPS201-TPS201.
2011
-
Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6619-6619.
2011
-
Assessment of clinical trials in oncology: An evaluation of 40,696 trials on ClinicalTrials.gov..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6095-6095.
2011
-
Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7003-7003.
2011
-
Relationship between relative dose intensity and mortality in women receiving combination chemotherapy for stage III-IV epithelial ovarian cancer..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
5084-5084.
2011
-
The role of biologic therapy in phase II breast cancer clinical trials..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
e13048-e13048.
2011
-
Use of gene expression profiling to determine prognosis and therapeutic targets for patients with appendiceal carcinoma..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
418-418.
2011
-
Daily administration of MGCD265 to patients with solid tumors in a dose-escalation phase I study (study 265-101)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3106-3106.
2010
-
Evaluation of Kras mutations and angiogenic biomarkers in patients with advanced non-small cell lung cancer (NSCLC) receiving single-agent sorafenib (S)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7626-7626.
2010
-
Phase II trial of bevacizumab (B) plus everolimus (E) for refractory metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
3535-3535.
2010
-
Treatment-related AML and AML evolving from MDS: Similar outcomes following treatment with amonafide plus cytarabine..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
6582-6582.
2010
-
Volumetric analysis of advanced thymic malignancies..
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7096-7096.
2010
-
A phase I trial of scutellaria barbata (BZL101) for metastatic breast cancer.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
1099-1099.
2008
-
Blast cells from patients treated for secondary AML (sAML) show less P-glycoprotein (Pgp)-mediated efflux of amonafide compared to daunorubicin: Implications for therapy.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
13536-13536.
2008
-
E/Tablets to collect research-quality, patient-reported data.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
17528-17528.
2008
-
Phase II study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.
7025-7025.
2008